Sort
30,917 grants matching “tumor microenvironment”
Role of p53 Missense Mutations on Tumorigenesis in Vivo
$384,750Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Role of p53 Missense Mutations on Tumorigenesis in Vivo
$384,750Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Imaging Hypoxia and Cancer Stem Cells
$384,750Zaver M Bhujwalla · Johns Hopkins University · R01 · FY2016 · CA
Role of p53 Missense Mutations on Tumorigenesis in Vivo
$384,750Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Imaging Hypoxia and Cancer Stem Cells
$384,750Zaver M Bhujwalla · Johns Hopkins University · R01 · FY2017 · CA
Synergy of Radiation and Immunotherapy: New Approaches
$384,750Yang-Xin Fu · Ut Southwestern Medical Center · R01 · FY2017 · CA
Cell of Origin and the Roles of Tumor Microenvironment in Neurofibroma Development and Therapeutics
$384,750Lu Le · Ut Southwestern Medical Center · R01 · FY2018 · CA
Synergy of Radiation and Immunotherapy: New Approaches
$384,750Yang-Xin Fu · Ut Southwestern Medical Center · R01 · FY2018 · CA
Signal transduction regulating tumor cell dissemination
$384,726John S Condeelis · Albert Einstein College Of Medicine · R01 · FY2019 · CA
Integration of neo-antigen vaccines and immune checkpoint therapy
$384,650Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2022 · CA
The Role of Lung Resident Mesenchymal Stem Cells in Post-Chemotherapy Lung Metastases of Breast Cancer
$384,644Guangwen Ren · Jackson Laboratory · R37 · FY2024 · CA
Tissue and Molecular Pathology (TMP)
$384,634Thomas James Giordano · University Of Michigan At Ann Arbor · P30 · FY2024 · CA
TGF&, PI3K and HER2 Pathways in Breast Cancer Metastasis
$384,627Joan Massague · Sloan-Kettering Inst Can Research · P01 · FY2014 · CA
Molecular Imaging of Metabolic Switches in Malignant Transformations
$384,617Heather Christofk · California Institute Of Technology · U54 · FY2013 · CA
(PQ7) Quantitative in vivo optical imaging of tumor heterogeneity
$384,612Melissa Caroline Skala · Morgridge Institute For Research, Inc. · R01 · FY2018 · CA
Phase 1/2 Study of Modern Immunotherapy in BCG-Relapsing Urothelial Carcinoma of the Bladder - (ADAPT-BLADDER)
$384,580Noah M Hahn · Johns Hopkins University · R01 · FY2021 · CA
Amoeboid Membrane Dynamics in Prostate Cancer
$384,579Michael R Freeman · Cedars-Sinai Medical Center · R01 · FY2014 · CA
Follicular Regulatory T-cells Promote Cancer
$384,562Jianmei Wu Leavenworth · University Of Alabama At Birmingham · R01 · FY2025 · CA
Transcriptional and epigenetic mechanisms of immunotherapy resistance in melanoma
$384,559Kai W Wucherpfennig · Massachusetts General Hospital · P01 · FY2019 · CA
Conditional Control of Drug Function Through α-Boryl Ether Oxidation
$384,484Paul E Floreancig · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · GM
Conditional Control of Drug Function Through α-Boryl Ether Oxidation
$384,484Paul E Floreancig · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · GM
Conditional Control of Drug Function Through α-Boryl Ether Oxidation
$384,484Paul E Floreancig · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · GM
Conditional Control of Drug Function Through α-Boryl Ether Oxidation
$384,484Paul E Floreancig · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · GM
Enabling effective anti-tumor immunity from targeted antibodies through dual innate and adaptive immune checkpoint blockade in non-immunogenic cancers
$384,482Zachary Conrad Hartman · Duke University · R01 · FY2024 · CA
Mechanoregulation of Nascent and Mature E-Cadherin Adhesions
$384,475Venkat Maruthamuthu · Old Dominion University · R15 · FY2015 · GM